Immunobiology

CD34+ megakaryoblastic leukaemic cells are CD38, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?

Abstract

The aim of this flow cytometry study in acute megakaryoblastic leukaemia (AML-M7) was to describe the membrane phenotype of CD34+ progenitor subsets and compare these with the phenotypes expressed by other AML FAB types. Following conventional histopathological diagnosis mononuclear cells from bone marrow and blood were examined in seven patients with AML-M7 and compared with results from 26 sequential patients with AML-M0 to AML-M6. The CD34+ subsets in AML-M7 patients differed from that of patients with AML-M0 to AML-M6 as the CD34+ CD61+ and the CD34+ Glycophorin A+ subsets were median 31% and 20%, respectively, compared to 4% and 2% in the AML-M0 to AML-M6 (P = 0.0005). Only 1% of the CD34+ progenitors were CD34+ CD38+ in AML-M7 compared to 72% in other AML subtypes (P < 0.000). these findings suggest that the cd34+ cell compartment in AML-M7 consists of early lineage-specific progenitors. In conclusion, flow cytometry analysis of CD34+ subsets may improve the diagnostic safety in AML-M7 and consequently the prognostic significance of immunophenotyping in acute leukaemia.

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Helleberg, C., Knudsen, H., Hansen, P. et al. CD34+ megakaryoblastic leukaemic cells are CD38, but CD61+ and glycophorin A+: improved criteria for diagnosis of AML-M7?. Leukemia 11, 830–834 (1997). https://doi.org/10.1038/sj.leu.2400648

Download citation

Keywords

  • acute megakaryoblastic leukaemia
  • flow cytometry
  • stem cell
  • CD34
  • CD61
  • glycophorin A

Further reading

Search